Bert Schepens

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model.

Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model.

Journal: Microbiology spectrum
Published: August 11, 2026

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Journal: Nature communications
Published: August 16, 2024

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery.

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery.

Journal: mAbs
Published: May 22, 2023

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.

Journal: EBioMedicine
Published: May 01, 2023

An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.

An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.

Journal: Journal of virology
Published: September 14, 2022

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.

Journal: Viruses
Published: January 28, 2022

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Journal: Science translational medicine
Published: October 05, 2021

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.

Journal: Cell death & disease
Published: September 06, 2021

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

Journal: mBio
Published: July 13, 2021

A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody.

A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody.

Journal: Journal of virology
Published: March 11, 2021

Single-domain antibodies make a difference.

Single-domain antibodies make a difference.

Journal: Science (New York, N.Y.)
Published: February 12, 2021

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Journal: Nature communications
Published: September 18, 2020
Showing 1-12 of 63

Last Updated: 09/26/2026